Accéder au contenu
Merck

L7877

Lactulose

≥95% (HPLC)

Synonyme(s) :

4-O-β-D-Galactopyranosyl-D-fructofuranose, 4-O-β-D-Galactopyranosyl-D-fructose

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

25 G

220.00 CHF

220.00 CHF


Vérifier la disponibilité des articles du panier

Demander une commande groupée

A propos de cet article

Formule empirique (notation de Hill) :
C12H22O11
Numéro CAS:
Poids moléculaire :
342.30
UNSPSC Code:
12352201
NACRES:
NA.25
PubChem Substance ID:
EC Number:
225-027-7
Beilstein/REAXYS Number:
93773
MDL number:

Passer à

Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Nom du produit

Lactulose, ≥95% (HPLC)

InChI key

JCQLYHFGKNRPGE-WJONTELPSA-N

InChI

1S/C12H22O11/c13-1-4-6(16)7(17)8(18)11(21-4)22-9-5(2-14)23-12(20,3-15)10(9)19/h4-11,13-20H,1-3H2/t4-,5-,6+,7+,8-,9-,10+,11+,12+/m1/s1

SMILES string

OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O

biological source

synthetic

assay

≥95% (HPLC)

form

powder

optical activity

[α]20/D -52.0 to -48.0 °, c = 4% (w/v) in water

color

white to off-white

mp

169  °C ((336 °F ))

solubility

water: 50 mg/mL, clear, colorless to faintly yellow

storage temp.

room temp

Quality Level

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Comparer avec des articles similaires

Voir la comparaison complète

Montrer les différences

1 of 4

Cet article
BP210L0130000427584
Lactulose British Pharmacopoeia (BP) Reference Standard

BP210

Lactulose

Lactulose European Pharmacopoeia (EP) Reference Standard

L0130000

Lactulose

assay

≥95% (HPLC)

assay

-

assay

-

assay

≥97% (HPLC)

biological source

synthetic

biological source

-

biological source

-

biological source

-

solubility

water: 50 mg/mL, clear, colorless to faintly yellow

solubility

-

solubility

-

solubility

water: 10 mg/mL

Quality Level

200

Quality Level

-

Quality Level

-

Quality Level

100

form

powder

form

solid

form

-

form

solid

storage temp.

room temp

storage temp.

2-8°C

storage temp.

-

storage temp.

15-25°C

Biochem/physiol Actions

Lactulose is a synthetic disaccharide derived from galactose and fructose. It is not absorbed in the gut and is frequently used in the treatment of constipation and hepatic encephalopathy. Studies have reported that lactulose administration may cause an increase in fecal nitrogen. It is also known to function as a prebiotic. Lactulose measurements can be used to detect gastrointestinal dysfunctions.

Other Notes

To gain a comprehensive understanding of our extensive range of Disaccharides for your research, we encourage you to visit our Carbohydrates Category page.

Classe de stockage

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Huifang Yin et al.
Carbohydrate research, 465, 58-65 (2018-06-27)
Oligosaccharides derived from lactulose (β-D-Galp-(1 → 4)-D-Fru) are drawing more and more attention nowadays because of their strong resistance to gut digestion, and the interest to discover novel prebiotics. Compared to galactooligosaccharides, currently known structures of lactulose oligosaccharides are very limited. In
Tara Raftery et al.
United European gastroenterology journal, 3(3), 294-302 (2015-07-03)
Vitamin D (vitD) supplementation may prolong remission in Crohn's disease (CD); however, the clinical efficacy and mechanisms are unclear. To determine changes in intestinal permeability (IP), antimicrobial peptide (AMP) concentrations and disease markers in CD, in response to vitD supplementation.
Edwin R Price et al.
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology, 164(2), 351-355 (2012-11-21)
Flying vertebrates have been hypothesized to have a high capacity for paracellular absorption of nutrients. This could be due to high permeability of the intestines to nutrient-sized molecules (i.e., in the size range of amino acids and glucose, MW 75-180
J Zhao et al.
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 26(6), 794-802 (2014-03-20)
Small intestinal bacterial overgrowth (SIBO) may be a cause of irritable bowel syndrome (IBS); however, current investigations have important limitations. We aimed to identify clinically relevant diagnostic criteria for SIBO based on lactulose hydrogen breath test (LHBT) alone and combined
C P Kelly et al.
Alimentary pharmacology & therapeutics, 37(2), 252-262 (2012-11-21)
Coeliac disease, an autoimmune disorder triggered by gluten ingestion, is managed by a gluten-free diet (GFD), which is difficult for many patients. Larazotide acetate is a first-in-class oral peptide that prevents tight junction opening, and may reduce gluten uptake and

Articles

Discover the role of carbohydrates in drug delivery, from solubility and stability improvement to advanced controlled-release systems.

Explore how carbohydrates function as excipients and carriers in drug delivery, with insights into mechanisms, case studies, and future trends.

Questions

Reviews

No rating value

Active Filters

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique